维普期刊资源整合服务平台（V6.5）

48篇 您的检索式：作者名="Monnet S"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Three thioredoxin targets in the inner envelope membrane of chloroplasts function in protein import and chlorophyll metabolism显示文摘	BARTSCH S MONNET J SELBACH K		0，，：	1
2	Phase Ⅱ study of oxaliplatin in poor - prognosis non - small cell lung cancer(NSCLC) 显示文摘	Monnet I Brienza S Hugret F	1998	Eur J Cancer1998，34，7：	1
3	Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes显示文摘	Albrich WC Monnet DL Harbarth S	2004	Emerg Infect Dis2004，10，3：	1
4	Oxaliplatin Plus Vinorelbine in advanced non-small-cell lung caner:final results of a multicenter phase II study 显示文摘	Monnet H Cremoux P Souli S	2002	Ann Orcol2002，13，1：	1
5	Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer(NSCLC)显示文摘	Monnet I Brienza S Hugret F		0，，07：	1
6	Quantitative detection of Corynebacterium casei in cheese by real-time PCR显示文摘	MONNET C CORREIA K SARTHOU A S	2006	Applied and Environmental Microbiology2006，72，11：	1
7	Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes显示文摘	Albrich WC Monnet DL Harbarth S		0，，03：	1
8	Prevalence of resistance to ampicillin, gentamicin and vancomycin in Enterococcus faecalis and Enterococcus faecium isolates from clinical specimens and use of antimicrobials in five Nordic hospitals显示文摘	Simonsen G S Smabrekke L Monnet D L	2003	Antimicrob Chemother2003，51，：	1
9	Phase Ⅱ study ofoxaliplatin inpoor-prognosis non-small cell lung cancer显示文摘	Monnet I Brienza S Hugret F	1998	Eur J Cancer1998，34，7：	1
10	Phase Ⅱ study of oxaliplatin in poor-prognosis non-small-cell lung cancer (NSCLC)显示文摘	Monnet I Brienza S Hugret F	1998	Eur J Cancer1998，34，7：	1
11	Oxaliplatin plus vinorelbine in advanced non-small-cell lung cancer: final results of a multicenter phase Ⅱ study显示文摘	Monnet H Cremoux P Souli S	2002	Ann Oncol2002，13，1：	1
12	Phaes II study of oxaliplatin in poor-prognosis non-small-cell lung cancer显示文摘	MONNET I BFIENZA S HUGRET	1998	Europ J of canner1998，34，7：	1
13	Prevalence of resistance to ampicillin, gentamicin and vanomycin in Enter- coccus faecalis and Enterococcus faecium isolates from clinical specimens and use of antimicrobials in five Nordic hospitals显示文摘	Simonsen G S Smabrekke L Monnet D L	2003	J Antimicrob Chemother2003，51，2：	1
14	Transient intestinal car-riage after ingestion of antibiotic-resistant Enterococcus faecium fromchicken and pork显示文摘	SΦRENSEN T L BLOM M MONNET D L	2001	The New England Journal of Medicine2001，345，16：	1
15	Phrase Ⅱ study of oxaliplatin in poor-prognosis non-small lung cancer (NSCLC)显示文摘	Monnet I Brienza S Hugret F	1998	Eur J Cancer1998，34，7：	1
16	Antibiotic selection pressure and resistance in Steptococcus pneummiae and streptococcus pyogenes显示文摘	ALBRICH W C MONNET D L HARBARTH S	2004	Emerg infec Dis2004，10，：	1
17	Aspartate biosynthesis is essential for the growth of Streptococcus thermophilus in milk, and aspartate availability modulates the level of urease activity显示文摘	ARIOLI S MONNET C GUGLIELMETTI S	2007	Applied and Environmental Microbiology2007，73，18：	1
18	Antibiotic selection pressure and resisrance in strep tococcus pneumonia and strep tococcus pyogenes显示文摘	Albrich W C Monnet D L Harbarth S	2004	Emerg infec Dis2004，10，：	1
19	Phase II study of oxali- platin in poor-prognosis non small cell lung cancer 显示文摘	Monnet I Brienza S Hugret F	1998	Eur J of Cancer1998，34，7：	1
20	Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes 显示文摘	ALBRICH W C MONNET D L HARBARTH S	2004	Emerg Infect Dis2004，10，3：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示